European Companies Search Engine
EU funding (€6,846,157): SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients Hor1 Jul 2022 EU Research and Innovation programme "Horizon"
Text
The filing refers to a past date, and does not necessarily reflect the current state.
The visualizations for "Associazione Frascati Scienza - EU funding (€6,846,157): SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.